SkinHealth Systems Inc. Operating Cash Flow
SkinHealth Systems Inc. (SKIN) reported Operating Cash Flow of -$2.88 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- SkinHealth Systems Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $2.67M, a 72.31% decline year-over-year.
- SkinHealth Systems Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.55M, a 285.38% decline year-over-year.
- SkinHealth Systems Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $15.20M, a 7.75% decline year-over-year.
- SkinHealth Systems Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $9.65M, a 6.48% decline year-over-year.
- SkinHealth Systems Inc. net cash provided by (used in) operating activities for fiscal 2025 was $37.48M, a 132.34% increase from fiscal 2024.
- SkinHealth Systems Inc. net cash provided by (used in) operating activities for fiscal 2024 was $16.13M, a 25.82% decline from fiscal 2023.
- SkinHealth Systems Inc. net cash provided by (used in) operating activities for fiscal 2023 was $21.75M.
- SkinHealth Systems Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$106.60M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.88M 10-Q · filed 2026-08-06 | $12.31M derived: sum of 3 quarters · filed 2026-08-06 | $21.96M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$5.55M 10-Q · filed 2026-05-07 | $9.64M derived: sum of 2 quarters · filed 2026-05-07 | $19.29M derived: sum of 3 quarters · filed 2026-05-07 | $28.93M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $24.84M derived: sum of 2 quarters · filed 2026-03-12 | $34.49M derived: sum of 3 quarters · filed 2026-08-06 | $37.48M 10-K · filed 2026-03-12 | |
| 2025-09-30 | $9.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $19.29M derived: sum of 2 quarters · filed 2026-08-06 | $22.29M 10-Q · filed 2025-11-06 | $38.76M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $9.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.64M 10-Q · filed 2026-08-06 | $29.11M derived: sum of 3 quarters · filed 2026-08-06 | $39.43M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $3.00M 10-Q · filed 2026-05-07 | $19.47M derived: sum of 2 quarters · filed 2026-05-07 | $29.78M derived: sum of 3 quarters · filed 2026-05-07 | $35.98M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $16.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $26.79M derived: sum of 2 quarters · filed 2026-03-12 | $32.99M derived: sum of 3 quarters · filed 2026-03-12 | $16.13M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $10.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $16.52M derived: sum of 2 quarters · filed 2025-11-06 | -$338.00K 10-Q · filed 2025-11-06 | -$5.51M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-06-30 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$10.65M 10-Q · filed 2025-08-07 | -$15.82M derived: sum of 3 quarters · filed 2026-03-12 | $2.14M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-03-31 | -$16.85M 10-Q · filed 2025-05-08 | -$22.02M derived: sum of 2 quarters · filed 2026-03-12 | -$4.06M derived: sum of 3 quarters · filed 2026-03-12 | $17.91M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2023-12-31 | -$5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $12.79M derived: sum of 2 quarters · filed 2026-03-12 | $34.76M derived: sum of 3 quarters · filed 2026-03-12 | $21.75M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $17.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $39.93M derived: sum of 2 quarters · filed 2024-11-12 | $26.92M 10-Q · filed 2024-11-12 | $21.53M derived: sum of 4 quarters · filed 2025-03-12 | |
| 2023-06-30 | $21.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.96M 10-Q · filed 2024-08-08 | $3.56M derived: sum of 3 quarters · filed 2025-03-12 | -$27.84M derived: sum of 4 quarters · filed 2025-03-12 | |
| 2023-03-31 | -$13.01M 10-Q · filed 2024-05-09 | -$18.40M derived: sum of 2 quarters · filed 2025-03-12 | -$49.80M derived: sum of 3 quarters · filed 2025-03-12 | -$81.14M derived: sum of 4 quarters · filed 2025-03-12 | |
| 2022-12-31 | -$5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$36.79M derived: sum of 2 quarters · filed 2025-03-12 | -$68.13M derived: sum of 3 quarters · filed 2025-03-12 | -$106.60M 10-K · filed 2025-03-12 | |
| 2022-09-30 | -$31.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$62.74M derived: sum of 2 quarters · filed 2023-11-14 | -$101.21M 10-Q · filed 2023-11-14 | -$97.93M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-06-30 | -$31.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$69.81M 10-Q · filed 2023-08-09 | -$66.53M derived: sum of 3 quarters · filed 2024-03-12 | -$66.23M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-03-31 | -$38.47M 10-Q · filed 2023-05-10 | -$35.19M derived: sum of 2 quarters · filed 2024-03-12 | -$34.89M derived: sum of 3 quarters · filed 2024-03-12 | -$68.09M derived: sum of 4 quarters · filed 2024-03-12 | |
| 2021-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $3.58M derived: sum of 2 quarters · filed 2024-03-12 | -$29.62M derived: sum of 3 quarters · filed 2024-03-12 | -$28.36M 10-K · filed 2024-03-12 | |
| 2021-09-30 | $298.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$32.90M derived: sum of 2 quarters · filed 2022-11-09 | -$31.64M 10-Q · filed 2022-11-09 | -$32.73M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$33.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$31.94M 10-Q · filed 2022-08-09 | -$33.03M derived: sum of 3 quarters · filed 2022-08-09 | -$33.03M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $1.26M 10-Q · filed 2022-05-10 | -$511.92K 10-Q · filed 2021-07-01 | $167.52K derived: sum of 2 quarters · filed 2022-05-10 | $166.98K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$1.09M derived: 10-K/A 6 month − 10-Q 3 month · filed 2021-05-28 | -$1.09M 10-K/A · filed 2021-05-28 | -$12.44M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | -$540.00 10-Q · filed 2020-11-16 | -$12.03M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$11.63M 10-Q · filed 2021-08-13 | ||||
| 2019-12-31 | $1.73M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |